Mutual Zonated Interactions of Wnt and Hh Signaling Are Orchestrating the Metabolism of the Adult Liver in Mice and Human by Kolbe, E. et al.
ArticleMutual Zonated Interactions of Wnt and Hh Signaling
Are Orchestrating the Metabolism of the Adult Liver
in Mice and HumanGraphical AbstractHighlightsd The Hh and Wnt pathways in healthy liver act largely
complementary to each other
d The Wnt/Hh module inversely controls spatiotemporal
metabolic pathways in the liver
d Inhibition of the Hh pathway leads to periportalization of the
liver lobe
d Liver-derived IHH seems to signal to other peripheral organsKolbe et al., 2019, Cell Reports 29, 4553–4567
December 24, 2019 ª 2019 The Author(s).
https://doi.org/10.1016/j.celrep.2019.11.104Authors
Erik Kolbe, Susanne Aleithe,
Christiane Rennert, ..., Jochen Hampe,




Wnt/b-catenin and Hh signaling
contribute to embryogenesis as well as to
the maintenance of organ homeostasis
through intensive crosstalk. Here, Kolbe
et al. describe that both pathways act
largely complementary to each other in
the healthy liver and that this crosstalk is
responsible for the maintenance of
metabolic zonation.
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The Hedgehog (Hh) and Wnt/b-Catenin (Wnt) cas-
cades are morphogen pathways whose pronounced
influence on adult livermetabolismhas been identified
in recent years. Howbothpathways communicate and
control liver metabolic functions are largely unknown.
Detecting core components of Wnt and Hh signaling
and mathematical modeling showed that both path-
ways in healthy liver act largely complementary to
each other in the pericentral (Wnt) and the periportal
zone (Hh) and communicate mainly by mutual repres-
sion.TheWnt/Hhmodule inversely controls thespatio-
temporal operation of various liver metabolic path-
ways, as revealed by transcriptome, proteome, and
metabolome analyses. Shifting the balance to Wnt
(activation) or Hh (inhibition) causes pericentralization
and periportalization of liver functions, respectively.
Thus, homeostasis of the Wnt/Hh module is essential
for maintaining proper liver metabolism and to avoid
the development of certain metabolic diseases. With
caution due to minor species-specific differences,
these conclusions may hold for human liver as well.
INTRODUCTION
The liver simultaneously fulfills a multitude of metabolic tasks with
partially opposingaims, suchassynthesis anddegradationof car-
bohydrates or lipids, which is a scenario that requires sophisti-
catedorchestrationbyvariousmechanisms tosatisfy thecomplex
metabolic requirementsof theorganism.Oneof these is thespatialCell Repor
This is an open access article undseparation of functions along the sinusoids, resulting in remark-
able metabolic heterogeneity of the hepatocytes. Based on their
position within the liver lobules, roughly two zones can be distin-
guished, namely, a pericentral (pc) zone close to the central vein
and a periportal (pp) zone located around the portal triads. The
zones of protein expression for some metabolic functions like
carbohydrate or xenobiotic metabolism are smooth, gradient-
like, and flexible, varying due to changes in the oxygen, hormone,
or nutrient levels (Gebhardt and Gaunitz, 1997; Kietzmann, 2017,
2019). Others like glutamine synthesis for ammonia detoxification
are surprisingly staticwith steepgradients fromone hepatocyte to
another (Gebhardt and Mecke, 1983). Research during the last
decade has shown that, in addition to the dynamic factors from
blood, morphogenic pathways, such as the Wnt/b-catenin (Wnt),
Hedgehog (Hh), members of the fibroblast growth factor (FGF)
family, and many more, are deeply involved in regulating meta-
bolism in the mature liver (Gebhardt and Matz-Soja, 2014).
Wnt and Hh signaling were originally known for their contribu-
tion in the developmental processes during embryogenesis and
are expressed in adult hepatocytes next to non-parenchymal liver
cells. Briefly, the Wnt pathway is triggered by the binding of
Wnt ligands to the receptor machinery consisting of Frizzled
(FZD) proteins and low-density lipoprotein-receptor-related pro-
tein (LRP5/6). Consequently, the cytosolic b-catenin (CTNNB1)
destruction complex, set up by adenomatous polyposis coli
(APC), axis inhibition protein (AXIN), glycogen synthase kinase-3-
b (GSK3b), and casein kinase-1 (CK1), is inactivated. Thus,
CTNNB1 is prevented from phosphorylation and subsequent
proteasomal degradation. As a result, CTNNB1 accumulates in
the cytoplasm, translocates to the nucleus, and binds to T cell
factor/lymphoid enhancer factor (TCF/LEF), which causes regula-
tion of the transcription of Wnt target genes (Figure S1) (Dai et al.,
2019). Active Wnt signaling can be attenuated through negativets 29, 4553–4567, December 24, 2019 ª 2019 The Author(s). 4553
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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regulators, such as secreted SFRP1 and Wnt inhibitory factor 1
(WIF1) (Cruciat and Niehrs, 2013). Furthermore, Wnt signaling is
controlledby theRSPO-LGR/RNF43-ZRNF3modulebyclearance
of FZD receptors (Rocha et al., 2015; Planas-Paz et al., 2016).
Hh signaling can be triggered by the binding of Hh ligands (e.g.
Indian Hh [IHH] and Sonic Hh [SHH]) to the receptor Patched
(PTCH). Ligand binding to PTCH leads to activation of the core-
ceptor Smoothened (SMO), which results in the release of the gli-
oma-associated oncogene transcription factors (TFs) (GLI1–3)
from the sequestering impact of suppressor of fused (SUFU).
Finally, the GLI factors translocate to the nucleus and activate
Hh-specific target genes (Figure S1) (Salaritabar et al., 2019).
Wnt signaling is required for the maintenance of the pc-based
metabolic phenotype (e.g., synthesis and xenobioticmetabolism),
whereas its inhibition causes a decrease in pc gene expression
and a concomitant increase in pp markers (e.g., urea synthesis
and b-oxidation) (Benhamouche et al., 2006; Burke and Tosh,
2006). Concerning the Hh pathway, it is known that inhibition of
its activity in adult hepatocytes leads to a disturbed IGF1 (insu-
lin-like growth factor) axis (Matz-Soja et al., 2014) and, in mutual
interaction with the liver circadian clock, to steatosis (Matz-Soja
et al., 2016; Marbach-Breitr€uck et al., 2019). It is known that
both pathways considerably interact during development (Kal-
deron, 2002; Song et al., 2015; Noubissi et al., 2018) as well as
in the adult stage in other organs (e.g., intestine [van den Brink
et al., 2004]). Therefore, we hypothesized that both pathways
also interact in the adult healthy liver and especiallywithin hepato-
cytes and, thus, orchestrate liver zonation in close cooperation.
Indeed, initial work in vitro showed that the TFs of the Hh cascade
positively influence the transcriptionof severalWntgenes, suchas
Wnt5a (Wingless-type MMTV integration site family, member 5a)
and Dkk1 (Dickkopf1) (Schmidt-Heck et al., 2015).
In the present work, we have investigated side by side (1) the
spatial cellular distribution of key compartments of the Wnt and
the Hh signaling and (2) the molecular interactions of both path-
ways in hepatocytes fromnormal and transgenicmicewith altered
or impaired activit. Furthermore, we have studied the metabolic
consequences of these alterations using various OMICs tech-
niques (transcriptome, proteome, and metabolome). Based on
these data, a mathematical model was developed that provides
the first insights into the mechanistic connection of the two path-
ways. The results of this study highlight the interconnections of
Wnt/Hh signaling in shaping zonation of the adult liver and their
fundamental relevance for the control of liver metabolism.
RESULTS
Wnt andHhAreHeterogeneously Distributed in the Liver
Parenchyma
Tostudy the localization of theWnt/Hhpathways,weanalyzed the
expression of selected core pathway genes in isolated hepato-Figure 1. Lobular Distribution of Wnt/Hh Gene and Protein Expression
(A) qPCR of Wnt pathway genes in isolated pp and pc hepatocytes from male C
(B) IHC and IFC of Wnt protein expression in male C57BL6/N liver sections.
(C) qPCR of Hh genes in isolated pp and pc hepatocytes from male C57BL6/N m
(D) IHC of Hh pathway proteins in male C57BL/N liver sections.
See also Figure S1.cytes from the pp and pc zones of C57BL6/N mice. Concerning
the Wnt controlling the RSPO-LGR4/5-ZNRF3/RNF43 module,
we could confirm dominant expression of Lgr5, Rspo1/3, and
Rnf4 in the pc hepatocytes compared with that in the pp ones
(Planas-Paz et al., 2016). However, Lgr4andZnrf3 showeda trend
to be more greatly expressed in the pp area (Figure 1A). The
expression ofWnt5a andWnt9b was lower in the pp area, which
was also indicated by immunohistochemistry (IHC) for the
WNT5A protein (Figure 1B). Similar gene expression and protein
translation along the pc zone could be observed for Fzd2. Like-
wise, the FZD4 protein showed a predominant staining in the pc
zone. In the case of the genes encoding so-called ‘‘destruction
complex’’ proteins, we detected only slight upregulation of
Ctnnb1, Gsk3b and Apc in the pc zone but no differences in the
expression of Axin2 (Figure 1A). In contrast, AXIN2 was strongly
zonated in the first two layers of hepatocytes around the central
vein that nicely corresponds to GLUL protein localization (Fig-
ure 1B). Asalreadypublishedby several groups, theCTNNB1pro-
tein could be detected in the pc zone (data not shown) (Benha-
mouche et al., 2006; Yang et al., 2014). For the mRNA of the
negative regulator genes of Wnt signaling, we observed a pp pre-
dominance of Sfrp1 andDkk1, as well as a pc preference forDkk3
andWif1 (Figure 1A). In the caseofWnt TFTcf4and transcriptional
target Myc, the gene expression was stronger in the pc hepato-
cytes, whereas Ccnd1 showed equal results.
Next, we asked how the Hh signaling components are local-
ized in the liver parenchyma. Concerning the Hh ligand Ihh, the
results clearly confirmed the already published pc zonation
(Gebhardt and Matz-Soja, 2014) (Figure 1C) but further showed
a strong colocalization with the Wnt-regulated proteins GLUL
and AXIN2 (Figure 1D). Interestingly, all other Hh-signaling-asso-
ciated genes with significant spatial preference showed a much
stronger expression in hepatocytes from the pp zone (Figure 1C).
In detail, we observed strong upregulation of the ligand Shh and
the receptorsPtch1 andPtch2 (Figure 1C). In the case of PTCH1,
the pp localization was also confirmed by IHC (Figure 1D). Addi-
tionally, the coreceptor Smo showed distinct higher expression
in the pp hepatocytes, which is also true for the negative regula-
tors Sufu and Fu. In the case of the TF of Hh signaling, only Gli3
showed significantly higher expression in the pp zone, whereas
Gli1 and Gli2 exhibited no zonal division (Figure 1C). Interest-
ingly, staining of the GLI proteins displayed predominant staining
in the cytoplasm in pc hepatocytes for GLI1 andGLI3 with a clear
nuclear staining in the case of GLI3 (Figure 1D), whereas GLI2
was not detectable (data not shown). The Hh-ligand-palmitoylat-
ing enzyme Hhat, as well as Disp1 and Disp2, responsible for
long-range Hh secretion, were found to have no significant zonal
preference (Figure 1C).
Regarding the zonation of Wnt signaling in humans, we were
able to detect CTNNB1 and LGR5 in human samples whereby
CTNNB1 shows congruent results to the pc localization inin C57BL6/N Mice
57BL6/N mice (n = 5–9). Data represented as mean ± SEM.
ice (n = 4–11). Data represented as mean ± SEM.
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Figure 2. Lobular Distribution of Wnt/Hh
Pathway Protein Expression in Humans
(A) IHC of Wnt proteins WNT5A, FZD4, LGR5,
AXIN2, and CTNNB1 on human liver biopsy slides.
(B) IHC of and Hh pathway proteins IHH, GLI1,
GLI2, and GLI3 on human liver biopsy slides.
See also Table S1.C57BL6/Nmice (Figure 2A). Inconsistentwith themurine situation,
the Wnt receptor FZD4 shows a scattered distribution spanning
the whole parenchyma (Figures 1B and 2A). Also, human
WNT5A and AXIN2 localization diverges from the murine-distinct
pc zonation. Looking at the Hh-related proteins, we were able to
depict a pc localization of the ligand IHH (Figure 2B). In addition,
the GLI proteins could be visualized. GLI1 andGLI3 show a strong
nuclear staining spanning the whole parenchyma, with the excep-
tion of single non-zonated cells with unstained nuclei (black ar-
rows). Incontrast,GLI2 is rather localized in thecytoplasmofsingle
randomly distributed hepatocytes (black arrows, Figure 2B).
These results are confirmed by previous studies in which hu-
man samples of the pp and pc region were obtained by laser
capture microdissection and analyzed for gene expression by
RNA sequencing (Brosch et al., 2018). The results show that cen-
tral genes of the Wnt pathway, such as AXIN2, LGR5, and
RSPO3, are also present pc in humans, where negative regula-
tors such as DKK3 are expressed pp (Table S1).
Activation of Wnt Leads to an Activation of the Hh
Pathway
To investigate the consequences of hepaticWnt pathway activa-
tion, the resulting impact on Hh signaling, and subsequent meta-4556 Cell Reports 29, 4553–4567, December 24, 2019bolic changes, we used Apchomo mice,
which carry a homozygous floxed exon
14 in the Apc allele (Shibata et al., 1997;
Ueberham et al., 2015). In the RSPO-
LGR4/5-ZNRF3/RNF43 module, the
downregulation of the negative regulator
Apc causes a significant decrease in
Lgr4 expression as well as a distinct
reduction of Rspo1 and Rspo3 in isolated
hepatocytes (Figure S2A). By contrast,
Lgr5, Rnf43, and Znrf3 showed significant
upregulation, indicating a fine-tuned
feedback mechanism of the downstream
target genes of the RSPO-LGR4/5-
ZNRF3/RNF43 module. Not less surpris-
ing due to Apc downregulation, there is
a strong upregulation of the Wnt ligand
and receptors Wnt5a, Fzd4, and Lrp5,
indicating Wnt activation. However,
the expression of Wnt9b and Fzd2 is
not affected due to Wnt activation
(Figure S2A). IHC analyses revealed
an enlargement of the WNT5A-, FZD2-,
and FZD4-expressing pc area zone of
Apchomo mice (Figure S2B). Referring to
the genes of the destruction complex,we confirmed the upregulation of Axin2 due to downregulation
of Apc by IHC (Colnot et al., 2004), whereas the expression of
Gsk3b and Ctnnb1 was not altered (Figures S2A and S2B).
Furthermore, co-localized zonal expansion of AXIN2 with the
GLUL protein was observed in Apchomo mice (Figure S2C). A
segmentation analysis of the expression shift of both proteins
by using the TiQuant software (Friebel et al., 2015) indeed
confirmed this co-localized enlargement by pixel quantification,
with an almost identical increase in the GLUL-stained area
(5.6-fold) with the AXIN2 stained area (5.7-fold) (Figure S2D).
However, the analysis also revealed a significantly larger
GLUL-stained area overlapping AXIN2 staining (GLUL-AXIN2)
due to Wnt activation. Considering the extracellular antagonists
of the Wnt signaling, a strong downregulation of Sfrp1 as well as
a reduction of Dkk3 and Wif1 was observed, whereas Dkk1
showed no changes. Additionally, the obvious expression in-
crease in the TF Tcf4 andMyc, as well as the slight downregula-
tion of Ccnd1, reflected the upregulation of the canonical Wnt
activity (Figure S2A).
To investigate the feedback ofWnt on the Hh pathway in hepa-
tocytes, we first analyzed the expression and protein translation
of several Hh components in the Apchomo mice. Considering the
ligands Ihh and Shh, only the expression of Ihh was affected by
Figure 3. Influence of APC Reduction on Hh Signaling Expression and Zonation
(A) qPCR of Wnt gene expression in isolated hepatocytes from ApcWT (n = 5–9) and Apchomo (n = 5–9) mice. Data represented as mean ± SEM.
(B) IHC of Hh proteins PTCH1, PTCH2, and GLI3 on ApcWT and Apchomo mice liver.
(legend continued on next page)
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the activation of Wnt signaling, as confirmed by IHC (Figures 3A
and 3C). On the protein level, IHH and AXIN2 showed distinct
colocalized expression in ApcWT that was strongly expanded in
Apchomo mice, indicating the direct dependency of IHH on Wnt
activity in single hepatocytes (Figure 3C).
Analyzing Hh receptors PTCH1/2 by IHC, we observed a con-
trary impact of Wnt activation in which PTCH1 pp expression
was lost, whereas PTCH2 expression was scattered over the
whole parenchyma (Figure 3B). The loss ofPtch1was not detect-
able by qPCR, whereas significant upregulation of Ptch2 was
observed in Apchomo mice (Figure 3A). The upregulation of
Ptch2 was also confirmed by a significant increase in the protein
level by western blot analysis in isolated hepatocytes of the Apc
mice (Figure 3D). Due to Apc downregulation, we also found an
upregulation of Smo, Fu, and Sufu (Figure 3A). Among the Hh
TFs, the expression of proteins that could form a repressor,
namely, Gli2 and Gli3, were positively affected due to the upre-
gulation of the Wnt signaling, whereas Gli1 showed lower
expression (Figure 3A). By performing GLI3 IHC, we revealed
that not only the amount of the protein increases but also the
expansion of the GLI3-positive cells followed a strong gradient
around the pc area in the Apchomo mice. However, in the ApcWT
mice, no pronounced zonation of the protein could be detected
(Figure 3B). Among prominent genes encoding proteins essential
for Hh secretion, we found a significant upregulation of Disp1
and a slight downregulation of Disp2, whereas the expression
of Hhat was not affected in the Apchomo mice (Figure 3A).
Deletion of Hh Signaling Triggers Transcriptional
Expression of Wnt Pathway
To address the question of how alteration of hepatic Hh signaling
can change theWnt cascade, we used transgenic SACmicewith
parenchymal-specific Hh inhibition by the deletion of the core-
ceptor Smo (Matz-Soja et al., 2014). A global view of the individ-
ual Hh signaling genes showed that the deletion of Smo in vivo
leads to decreased expression of Ihh and Shh, as well as that
of the TF Gli1 and Gli3 (Figure S3). Regarding the expression
of Hh negative feedback molecules, Ptch1 was increased and
Hhip1 was downregulated, whereas Fu and Sufu were not
affected.Hhatwas strongly upregulated, wehreasDisp2 showed
a slight decrease (Figure S3).
Concerning Wnt signaling, the deletion of Smo resulted in a
strong upregulation of the RSPO-LGR4/5-ZNRF3/RNF43 mod-
ule (Figure 4A). Furthermore, the expression of Wnt5a, Fzd4,
Fzd2, and Lrp5 was increased, whereas Wnt9b displayed no
change (Figure 4A).
This increase in gene expression was not accompanied by an
expansion of the protein expression zone in IHC for WNT5A,
FZD4, and FZD2, as observed in Apchomo mice. The zonal
spreading was rather identical between SAC-knockout (KO)
and SAC-wild-type (WT) mice (Figure 4B), indicating that Hh
signaling does not control the spatial expression ofWnt signaling
and that the mechanisms are subject to very distinct and fine-(C) IF double staining of Wnt target protein AXIN2 and Hh ligand IHH on ApcWT a
(D) PTCH2 immunoblot analysis of isolated hepatocytes from ApcWT (n = 4) and
represented as mean ± SEM.
See also Figure S2.
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Axin2, which is significantly upregulated in isolated hepatocytes
of SAC-KO mice, whereas no significant increase in the number
of AXIN2- and GLUL-expressing hepatocytes could be visual-
ized by immunofluorescence (IF) (Figure 4C). However, concern-
ing the segmentation analysis of the individual protein distribu-
tion, the GLUL-positive zone harbored a markedly lower
number of AXIN2-positive hepatocytes in the SAC-KO than
that in the SAC-WT mice (GLUL-AXIN2) (Figure 4D). Conversely,
a significant increase was found in AXIN2-positive hepatocytes
outside the GLUL-positive zone (AXIN2-GLUL) (Figure 4D), a
finding that is in line with the upregulation of Axin2 at the
mRNA level. However, the IHC of CTNNB1 indicated no stronger
Wnt activity because it displayed no increase in nuclear staining
(data not shown), although the expression of the Ctnnb1 gene
was significantly increased in hepatocytes from SAC-KO mice
(Figure 4A). Interestingly, genes encoding proteins for the nega-
tive regulators of Wnt signaling, such as Sfrp1, Dkk3, and Wif1,
were upregulated, whereas Dkk1was not affected. Correspond-
ingly, no change was found in the expression of Tcf4 due to Smo
deletion (Figure 4A).
Mathematical Model for Wnt/Hh Crosstalk and Spatial
Patterning
Given the large complementary localization of Wnt and Hh path-
ways and their mutual interaction, we asked whether the
complexity could be reduced by a mathematical model. The
experimental base for constructing this model were the results
mentioned above and further gene expression analyses of Wnt-
and Hh-related genes after in vitro small interfering RNA (siRNA)
knock down of several Wnt/Hh pathway targets (Figure S4A).
From the in vitro knockdown data, a condition-dependency
network was constructed depicting the relations of Wnt and Hh
genes in response to the siRNA knockdowns (Figure S4B).
To analyze how the response of each gene to the knockdown
is correlated to every other gene, a clustered correlation matrix
was constructed (Figure 5A). The heatmap depicts the choice
of gene activation versus inhibition along with hierarchical clus-
tering analysis of correlation coefficients. We observed that
some core Hh genes (Smo, Ihh, Shh, Fu, and Gli3) are strongly
correlated with each other and grouped into one cluster. The
same does not appear to be true for theWnt pathway genes (Fig-
ure 5A). In line with our observation in the Apchomo mice, Ptch1
and Ptch2 behave differently and were clustered far away within
the correlation tree (Figures 3B and 5A).
From the cumulative in vivo and in vitro data, the model was
constructed to simulate the spatial interactions of Wnt and Hh
within the liver lobule (Figure 5B).We used the following assump-
tions in the model: Wnt ligands are secreted throughout the
computational domain but predominantly by the central vein
and diffuse. Wnt ligands activate the intracellular Wnt compo-
nents and are counteracted by APC. Furthermore, the analysis
revealed that the Wnt ligands Wnt5a and Wnt9b are bothnd Apchomo mice liver sections.
Apchomo (n = 4) mice (left). b-Actin (ACTB) was used as loading control. Data
Figure 4. Deletion of Hepatic SMO Lead to Local Activation of Wnt Pathway
(A) qPCR of Wnt gene expression in isolated hepatocytes from SAC-WT (n = 3–7) and SAC-KO (n = 4–7) mice. Data represented as mean ± SEM.
(B) IF double staining of Wnt targets AXIN2 and GLUL on SAC-WT and SAC-KO mice liver sections.
(legend continued on next page)
Cell Reports 29, 4553–4567, December 24, 2019 4559
negatively correlated with Shh, whereas the intracellular compo-
nents of theWnt pathway showed no obvious correlation pattern
(Figure 5A). Supported by these anti-correlated responses of
Wnt5a, Wnt9b, and Shh and the lack of spatial co-localization
between the Wnt ligands and SHH, we assume that the
maximum possible intracellular Wnt pathway activity is
decreased by the presence of SHH.
Moreover, we make the simple assumption in the model that
Wnt ligands suppress SHH expression. From the concomitant
reduction of Shh by Smo deletion, we assume that SHH is acti-
vated by SMO and diffuses. IHH is activated by both SMO and
the intracellular Wnt pathway components (Figure 5A). The latter
assumption is inferred by the observed expression patterns (Fig-
ure S4A). Finally, from the unidirectional expression of GLI3 and
IHH in our animal models and the positive correlation of GLI3 and
SHH in the gene to knockdown the response matrix (Figure 5A),
we assume GLI3 activation by both IHH and SHH.
The control, Apchomo, SAC-KO, and combined Apchomo/SAC-
KO cases are depicted in Figure 5B. Each panel represents the
same tissue domain, chosen slightly larger than a single liver
lobule shown in the middle of the 2D cross section. The simula-
tion results for individual model components are displayed as
color-coded concentration fields: white for zero concentration
and more saturated color for higher concentrations. In all cases,
there were higher concentrations of Wnt pc and SHH pp. Crucial
for this pattern was the increased production of Wnt pc and inhi-
bition of SHH by Wnt. The intracellular components of the Wnt
pathway were also strongest pc, the expression zone expanded
upon decreasing APC, and their peak expression increased in
SAC-KO (compare with Figures 4 and S2). IHH showed a pattern
similar to the intracellular Wnt components but was decreased in
the SAC-KO case, in contrast to the intracellular Wnt compo-
nents that were increased in the SAC-KO case. GLI3 was ex-
pressed more pp in the control and more pc in the Apchomo
case (compare with Figures 4 and S2).
By invoking the changes in Apchomo and SAC-KO simulta-
neously, we can simulate a combined Apchomo/SAC-KO case
(see Figure 5B). We obtained an increased expression zone of
the intracellular Wnt components and IHH similar to the Apchomo
scenario and changes in expression levels with similar quantity
as the SAC-KO case.
Themodel can also account for the expression patterns ofWnt
and Hh pathway components that have been observed in hu-
mans (Figure 2). To reproduce these patterns, we can use the
same model structure as that developed for the mouse and
only change a few parameter values, corresponding to quantita-
tive differences of rate constants and/or expression levels be-
tween both species. In fact, it turns out that changing the para-
maters in the equation for Wnt only (slower diffusion, increased
uniform production, and increased degradation rates) is suffi-
cient to qualitatively reproduce the observed patterns (Fig-
ure 5B). The simulations then correctly reproduce both charac-(C) IHC of Wnt proteins CTNNB1, FZD2, FZD4, and WNT5A on SAC-WT and SA
(D) Quantification of AXIN2/GLUL double staining on SAC-WT (n = 3) and SAC-KO
brief: positive-stained area (GLULWT/KO; AXIN2WT/KO), colocalized positive-st
is not detected (GLUL-AXIN2 WT/KO), and positive-stained AXIN2 area where G
See also Figure S3.
4560 Cell Reports 29, 4553–4567, December 24, 2019teristic differences: a larger background concentration of Wnt
and a smaller zone around the central vein with further increased
Wnt (Figure 5B). The predicted patterns of IHH and Wnt compo-
nents are similar as those in mice, and Gli3 expression is almost
constant. All these simulation results correspond very well to the
observed patterns in Figure 2 and, where not measured yet,
represent additional testable model predictions.
Metabolic Consequence of the Modulation of Wnt and
Hh Signaling in the Liver
To explore the influence of Wnt/Hh signaling on hepatic meta-
bolism, isolated hepatocytes of the transgenic as well as sepa-
rated pp and pc cells from C57BL6/N mice were cultivated up
to 24 h. After hepatocyte cultivation, the supernatant was used
to determine the extracellular metabolite status by liquid chro-
matography-mass spectrometry (LC-MS). The obtained data
were evaluated using MetaboAnalyst software (Chong and Xia,
2018). In general, principal-component analysis (PCA) showed
clear separation between the WT and KO samples from the
Apc and SAC mice, as well as between the pp and pc fractions,
indicating distinct differences in the extracellular metabolites in
the opposing groups (data not shown).
An initial global examination of the data showed a different
pattern of changes in amino acid (aa) concentrations in cultures
of pp and pc hepatocytes (Figure 4A). After deleting Smo in
SAC-KOmice, the enrichedmetabolite sets resemble those of he-
patocytes in the pp area, whereas activation of the Wnt pathway
leads to a more pc-like metabolite set enrichment (Figure S5A).
For instance, a broad set of aas (e.g., glutamine, histidine, tyro-
sine, tryptophan, and serine) showed lower abundance in the su-
pernatant of pp cells compared with that in pc cells, which can
also be detected for SAC-KO compared with SAC-WT hepato-
cytes. In contrast, the Apchomo hepatocyte supernatant showed
a pc-like metabolic signature. Quantitativemetabolite enrichment
analysis revealed a large set of metabolic liver functions that were
zonated, including well-known zonated metabolic pathways,
such as the urea cycle, glutamate metabolism, glycolysis, and
aa metabolism, and many of them showed significant changes
between the WT and KO samples of both tramsgenic mouse
models, corresponding to the changes between pp and pc hepa-
tocytes (Figure S5B). For example, the urea cycle was signifi-
cantly upregulated in hepatocytes from the pp area as well as in
the SAC-KOmice, whereas no change was measured in Apchomo
mice, a finding that was also true for glutamate metabolism.
Regarding the urea cycle, the hepatocytes from the Apchomo
mice consumed a lower concentration of arginine that was
also true for the hepatocytes derived from the pc area (Figure 6A).
By contrast, the hepatocytes from the SAC-KOmice displayed a
much higher consumption of arginine than the SAC-WT mice,
indicating a more pp behavior. The deletion of the Hh signaling
also caused a significant increase in the ornithine concentration
in the culturemedium comparedwith that in the SAC-WT, a trendC-KO mice liver slides.
(n = 4) mice liver sections by TiQuant software. The different segmentations in
ained area (GLUL and AXIN2WT/KO), positive-stained GLUL area where AXIN2
LUL is not detected (AXIN2-GLUL WT/KO). Data represented as mean ± SEM.
Figure 5. Results of the In Vitro Data Analysis and the Mathematical
Model for Wnt/Hh Cross Talk and Spatial Patterning, See Also Fig-
ure S4
(A) Clustered correlation matrix showing pairwise correlations between
measured gene expression levels for gene-specific expression responses to
knockdowns (red: positive correlation, blue: negative correlation, gray: no
correlation). Genes of the Hh pathway are marked in green and genes of the
Wnt pathway are marked in orange.
(B) Results of the mathematical model for the Control, Apchomo, SAC-KO, and
combined Apchomo /SAC-KO and human conditions. White corresponds to
zero concentration, and increasing color saturation refers to higher concen-
trations. Five panels in each row show the spatial concentration fields, ob-
tained simultaneously at steady state, for Wnt ligand (w), intracellular Wnt
pathway activity (b), IHH ligand (i), SHH ligand (h), and GLI3 (g). Different colors
serve to distinguish individual rows. The spatial domain is chosen to cover one
hexagonal lobule in the center surrounded by parts of adjacent 6 lobules.
See also Figure S4.that was also found in the supernatant of the pp cells compared
with that in the pc cells (Figure 6A). The final amount of secreted
urea was, as expected, considerably smaller in the supernatantof hepatocytes from Apchomomice than that seen in the pc cells.
The higher amount of urea in the supernatant of the SAC-KO he-
patocytes confirmed the periportalization of the cultured hepato-
cytes (Figure 6A).
To investigate the underlying mechanism of this observation,
we performed shotgun proteomics analysis of liver material
from the transgenic mice and analyzed the data using Ingenuity
Pathway Analysis (IPA) software (Kra¨mer et al., 2014). The results
showed that the activation of theWnt pathway led to a significant
downregulation of core proteins in the urea cycle (e.g., ASL,
ARG1, and ASS1), leading to the prediction of the downregula-
tion of the whole pathway. By contrast, the prediction of the up-
regulation of the urea cycle in the SAC-KOmice resulted from the
strong upregulation of CPS1 and the OTC enzyme (Figure 6A;
Table S2). Although not a part of the urea cycle, glutaminase is
an important enzyme for pp nitrogen metabolism that is pre-
dicted to be upregulated in SAC-KO mice and downregulated
in Apchomo mice.
Additionally, the catabolism of aas, which is predominantly
localized in the pp area, was strongly upregulated in hepatocytes
from SAC-KO mice (e.g., consumption of histidine, glutamine,
serine, and tyrosine), whereas mice with activated Wnt signaling
showed a downregulation of these aas (Figure 6B). These results
were also confirmed by the IPA network analysis of SAC-KO
mice that showed upregulation of enzymes involved in serine
catabolism, (e.g., serine dehydratase and serine hydroxymethyl-
transferase), glutamine catabolism (e.g., glutaminase and gluta-
mic-oxaloacetic transaminase), and tryptophan catabolism (e.g.,
indolamin-2,3-dioxygenase and arylformamidase). On the other
hand, for Apchomo mice, the analysis revealed a downregulation
or no change in the expression of those enzymes that were up-
regulated in SAC-KO mice (Figure 6B; Table S3).
Because space does not allow us to present all affected meta-
bolic pathways in detail, another example from lipid metabolism
shall demonstrate that the responses to Hh and Wnt modulation
follow the same pattern. For instance, cholesterol transport in
SAC-KOmice was downregulated, whereas it appeared upregu-
lated by Wnt activation (Figure 6C; Table S4). In detail, proteins
involved in lipoprotein formation and vesicular transport, such
as APOA1, APOE, and CLU, were downregulated in SAC-KO
mice but were upregulated in Apchomo mice.
To find a mechanism behind the regulation of pp functions by
Hh signaling, we first clarified the question about whether the
ligand IHH, which is the only pc-located Hh component, is
responsible for this observation. Therefore, we studied IHH
and SHH gain-of-function as well as loss-of-function analyses
in vitro. The results show that a 48-h incubation with the recom-
binant IHH (rec IHH) protein leads to an increase in almost all
genes investigated, whereby cholesterol biosynthesis (Hmgcr,
Hmgcs, and Cyp7A1) was particularly strong affected after
48 h (Figure S6A). In contrast, increasing Hh activity by recombi-
nant SHH (rec. SHH) did not result in significant changes of the
investigated genes. Solely, a trend for an increase of Otc and
Cps1 by rec. SHH can be observed (Figure S6A).
To carry out IHH and SHH loss-of-function analyses, RNA
interference experiments were performed. The deletion of Ihh
shows a strong downregulation of the investigated genes after
an incubation period of 72 h, whereby, again, the cholesterolCell Reports 29, 4553–4567, December 24, 2019 4561
(legend on next page)
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biosynthesis is mostly affected. In response to the deletion of
Shh, no clear effects could be found due to mutual variations
of the measured values (Figure S6B).
With regard to the function of IHH in vivo, we bred transgenic
animals with hepatocyte-specific deletion of IHH and performed
microarray analyses of liver tissue. To link the obtained data to
pp-localized metabolic pathways, we searched the array for
the studied in vivo genes, such as urea synthesis (Cps, Arg1/1,
Asl1, Ass1, and Otc) and cholesterol metabolism (Hmgcr/l/s)
(Figure S6C). The results suggest that IHH produced by the liver
in vivo does not directly affect pp functions.
To show whether Hh signaling influences pp zonation by Gli
TFs, we activated the Hh signaling pathway in hepatocytes of
non-transgenic C57BL/6Nmice in vitro by overexpression exper-
iments (Figure S7). The cells were transfected individually with
GLI1, GLI2, and GLI3 plasmid DNA, as well as in combination of
all three TFs. The results of these analyses show that many of
the genes examined react quite differently to the overexpression
of the individual GLI factors. The genes of the urea metabolism
(Arg1, Otc, and Cps1) show a decreased expression due to the
overexpression of GLI1, whereas transfection with GLI2 and
GLI3 lead to an increase of these genes compared to the mock
control. The combination of all 3 TFs also shows an increase in
the expression of the genes of the urea cycle, whereby the inhib-
itory effect of GLI1 is most likely masked by GLI2 and GLI3. In
contrast, in the case of cholesterol metabolism, the overexpres-
sion of GLI1 seems to lead to an increase in the genes studied,
which also applies to GLI2 and GLI3 (Figure S7).
DISCUSSION
The present study reveals insights into the regulation of meta-
bolic liver zonation by the morphogen Wnt and Hh pathways,
demonstrating their largely complementary lobular distribution
and providing a paradigm for their mutual interplay in liver paren-
chyma. For the Wnt signaling, the known pc expression of core
pathway components (Sekine et al., 2006; Braeuning and
Schwarz, 2010; Preziosi et al., 2018) and of some members of
the RSPO-LGR4/5-module (Planas-Paz et al., 2016), such as
Rspo1/3, Lgr5, and Rnf4 could be confirmed, whereas other
components like Lgr4 and Znrf3 tended to be more highly ex-
pressed pp. Themost spectacular findings, however, concerned
the impact of Wnt activity on the Hh cascade in adult hepato-
cytes, which had not been investigated before.
With respect to Hh signaling, we showed that the zonal distri-
bution of its members, except IHH but including SHH and the HhFigure 6. Alteration in Metabolic Zonation by Wnt/Hh Modulation
(A) IPA results for the urea cycle of proteome analysis data from liver material of A
mice (left) and column representation of urea cycle metabolites in hepatocyte cu
versus SAC-KO (n = 3) mice and pp (n = 3) versus pc (n = 4) hepatocytes from C
content was performed. Data represented as mean ± SEM.
(B) IPA results for aa degradation of proteome analysis data from liver material of A
mice (left) and column representation of several aas in hepatocyte culture superna
(n = 3) mice and pp (n = 3) versus pc (n = 4) hepatocytes from C57BL6/N mice afte
Data represented as mean ± SEM.
(C) IPA results for cholesterol transport of proteome analysis data from liver mate
(n = 4) mice.
See also Figures S5, S6, and S7 and Tables S1–S6.negative regulator Sufu, dominated in the pp area. Because
SUFU is also known to be a negative regulator of Wnt signaling
(Meng et al., 2001), its pp localization suggests a contribution
to a pp Wnt antagonism. In contrast to other Hh pathway mem-
bers, IHH is an exception and was expressed most distal from
the portal vein, almost co-localized with AXIN2 (Figure 7). In
accordance with the spatial separation between IHH and SHH,
we found a highly elevated mRNA level of Ihh in conjunction
with circular expansion around the central vein in Wnt-activated
Apchomo mice, whereas SHH did not respond. Interestingly, the
negative regulators Ptch2, Sufu, and Gli3 (potential repressor)
were also upregulated in vivo. Thus, Wnt signaling seems to sup-
press pp Hh signaling but triggers the pc expression of IHH. This
result may be a first indication that IHH has a completely different
function in hepatocytes than is known from other tissues. Hh-
ligand-secreting Disp1 that is responsible for long-range Hh
signaling (Caspary et al., 2002) is also increased by Wnt activa-
tion in Apchomo mice, suggesting that IHH is formed as a secre-
tory protein in the pc zone to transmit essential information from
the liver to the periphery. This hypothesis is supported by the re-
sults of IHH modulation in vivo. The results show that a hepato-
cyte-specific deletion of IHH does not lead to a change in the pp
functions studied, such as urea cycle and cholesterol meta-
bolism. We interpret this result as a strong hint that liver-derived
IHH signals to other (peripheral) organs, whereas liver pp meta-
bolism is regulated by IHH from other sources, most probably
the gut by the portal vein. The finding that IHH, but not SHH or
DHH, travels by VLDL (Very low-density lipoprotein) in human
blood (Queiroz et al., 2010) supports this hypothesis. In addition,
we recently demonstrated that the IHH protein shows an oscilla-
tory hepatic expression behavior that can also be detected in the
serum of mice (Marbach-Breitr€uck et al., 2019).
The impact of Wnt signaling on the Hh pathway and vice versa
was analyzed bymathematical modeling on the basis of the data
obtained in vivo and in vitro from the Apchomo and the SAC-KO
mice. The model suggests that by assuming a steady gradient
ofWNT ligands from the central vein to the portal triad, themutual
negative correlation between SHH and WNT ligands is able to
match the zonal distribution of Wnt and Hh activities in control
and transgenic mice. Because IHH is activated by both SMO
and intracellular Wnt pathway components, it is clear that the
two Hh ligands play a different role in the liver even though both
ligands positively influenceGLI3. This reflects a dramatic change
in a fundamental paradigmbecause so far it was thought that IHH
would represent the hepatocellular activity of this pathway rather
than SHH. In other organs, the manner in which both pathwayspcWT (n = 5) versus Apchomo (n = 6) and SAC-WT (n = 4) versus SAC-KO (n = 4)
lture supernatants from ApcWT (n = 3) versus Apchomo (n = 5), SAC-WT (n = 5)
57BL6/N mice after 24-h incubation time (right). Normalization to total protein
pcWT (n = 5) versus Apchomo (n = 6) and SAC-WT (n = 4) versus SAC-KO (n = 4)
tant from ApcWT (n = 3) versus Apchomo (n = 5), SAC-WT (n = 5) versus SAC-KO
r 24-h incubation. (right). Normalization to total protein content was performed.
rial of ApcWT (n = 5) versus Apchomo (n = 6) and SAC-WT (n = 4) versus SAC-KO
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Figure 7. Interplay of Wnt and Hh Activity and
Its Influence on Metabolically Zonated Path-
ways
(A) The Wnt (violet circle) and the Hh pathway (or-
ange circle) in the normal state. Most of the Wnt-
associated members are zonated in the pc area,
whereas central Hh members are located in the pp
area. The metabolically zonated pathway are in
balance (blue circle represents pc localizated
metabolic functions; pink circle represents pc
localized metabolic functions).
(B) The activation of pc Wnt activity by Apc down-
regulation leads to a locally increase in Hh activity.
The pc-zonated metabolic pathways become over-
represented, whereas the pp program is decreased.
(C) The inhibition of the pp-localized Hh leads
to a locally limited increase in Wnt activity. The
pp-zonated metabolic pathways become over-
represented, whereas the pc program is decreased.communicate is controversial. In the adult gut, both pathways
interact in an antagonistic way inwhichGli1 inhibitsWnt signaling
at a level below b-catenin phosphorylation (van den Brink et al.,
2004). One potential protein that acts as an interface between
the two pathways in most tissues is the soluble modulator
SFRP1, which is known to antagonize Wnt signaling (Planas-
Paz et al., 2016; Ding andWang, 2017). However, our results indi-
cate a more subordinate role of SFRP1 in the interplay of both
pathways in hepatocytes. In SAC-KO mice, the expression of
Sfrp1 shows an upregulated trend but is strongly downregulated
byWnt activation inApchomomice.Other proteins that serve asan
intersection between the two pathways, such as GSK3b,
CTNNB1, GLI1, and GLI3R, have been described (Song et al.,
2015). In dorso-ventral patterning, Wnt antagonizes Hh signaling
through the expression of the GLI repressor GLIR (Alvarez-
Medina et al., 2008; Ulloa and Martı´, 2010). However, all the
described interaction concepts known for different types of can-
cer fail to explain the interaction ofWnt andHh in the healthy liver.
Therefore, we support the theory that Wnt and Hh cross talk oc-
curs in a tissue- and metabolic-specific manner, a result of inte-
grated, context-dependent cellular responses (Sethi and Vidal-
Puig, 2010). This intercellular concept has also been described
for the intestinal epithelium (Katoh and Katoh, 2006).
In contrast to liver zonation of Wnt and Hh in rodents, the
knowledge about the human situation is rather rudimentary.
The cause is most likely the difficult acquisition of unaltered4564 Cell Reports 29, 4553–4567, December 24, 2019healthy human liver tissue and, as also indi-
cated by our results, a partially different
localization in humans than in mice. For
example, WNT5A was expressed in the pc
area in mice, whereas in humans, the local-
ization occurs in the pp zone (Beljaars et al.,
2017). Furthermore, Brosch et al. (2018)
demonstrated pc zonation of Axin2 by
transcriptome analysis of laser micro-
dissected pp and pc human hepatocytes,
which was also shown in our data. Con-
cerning human Hh signaling proteins, wefound IHH to be located pc, as already demonstrated in mice
(Gebhardt and Matz-Soja, 2014). In addition, we showed that
TF GLI1 and GLI3 are expressed in the nuclei of human hepato-
cytes under normal conditions, whereas GLI2 expression was
solely cytosolic in single randomly distributed cells. This demon-
strates that the Hh pathway is also active in the adult human liver
where it might contribute to metabolic liver homeostasis, as has
already been proven in mice (Matz-Soja et al., 2016). Although
the morphogen pathways make an immense contribution to
maintaining liver homeostasis, particularly in humans (Verdelho
Machado andDiehl, 2018; Li et al., 2019), considerable additional
work is needed to specify this in detail. Because the mathemat-
ical model established in the context of this work for the interac-
tion of the Hh and the Wnt pathway in the mouse can also repro-
duce the results in humans very well, this model can be used in
such future investigations on the limited liver material of patients.
The interplay ofWnt andHh signaling described above is of the
utmost importance for the regulation of metabolic liver zonation,
as demonstrated by combining global gene expression, prote-
ome data, andmetabolome data obtained from cultured hepato-
cytes of ppandpcorigin or isolated from the transgenicmicewith
modulated Wnt and Hh signaling. The range of metabolic func-
tions analyzed covered the entire spectrum of liver metabolism
and comprised examples from carbohydrate, aa, and lipid meta-
bolism but also bile acid synthesis, oxidative stress, and drug
metabolism, just to name a few (Figure S5 shows 50 examples).
All of themwere clustered according to their pp or pc prevalence.
Further analyses revealed that most of them responded to
changes in Hh and Wnt activity depending on whether they be-
longed to the pp and pc clusters, respectively. Thus, loss of Hh
activity by Smo leads to a dominance of pp functions, whereas
activation of Wnt by APC knockout enhances pc functions. Con-
cerning modulation of the Wnt pathway, similar findings were
already deduced from gene expression studies, mainly with
respect to ammonia detoxification (Benhamouche et al., 2006;
Sekine et al., 2006) but not supported by metabolic studies. In
the case of Hh modulation, we recently demonstrated that a
loss of Hh activity strongly affects lipid metabolism (represented
bypp-localized steatosis) andshifts the zonationofPPAR (Perox-
isome proliferator-activated receptor alpha) TFs to a more pp
localization (Matz-Soja et al., 2016). Moreover, in SAC-KO mice
the synthesis of IHH is lowered but remains its circadian rhythmic
expression in a narrow pc zone (Marbach-Breitr€uck et al., 2019).
As illustrated by our mathematical model, both morphogen
pathways indeed contribute differently the alterations in meta-
bolic zonation. Impairment of Hh affects mainly the capacity of
the respective metabolic function, i. e. upregulation of pp func-
tions and downregulation of pc functions. In contrast, activation
of Wnt affects not only the capacity, but also leads to a pro-
nounced extension of the pc expression zone of respective en-
zymes, e. g. glutamine synthetase, and reduces pp localized
functions. These different patterns illustrated in Figure 7 could
also be corroborated by our proteome studies and IHC of
selected enzymes. The complex interplay of Wnt and Hh
signaling pathways in liver and its global impact on metabolic
zonation calls for intensive studies of the molecular mechanisms
involved. Regulation of gene expression via various TFs may be
one of them. Although some detailed studies of selected cases
have been reported (Werth et al., 2006; Schmidt-Heck et al.,
2015), even major regulatory steps within the Wnt/Hh module
remain enigmatic. One such example is the role of GLI factors
and their regulation in hepatocytes. Although the Gli3 mRNA is
much more strongly expressed in the pp area of the liver lobuli
(Figure 1C), the localization of the GLI3 protein seems to domi-
nate in the pc area (Figure 1D) where it is strongly enhanced
when Wnt signaling is activated (Figure 3B). This lead to the hy-
pothesis that here the repressor form of the GLI3 protein is
affected by Wnt activity, resulting in increased suppression of
pp metabolic functions. In SAC-KO mice, where Gli3 is almost
lost (Matz-Soja et al., 2016), no repression may be active, thus,
leading to the observed increase of pp functions. Unfortunately,
this scenario cannot be easily reproduced in vitro. This demon-
strates the complexity of the interplay of the GLI factors and the
need for further investigation, which may show what a possible
GLI code for the regulation of hepatic pp functionsmight look like.
Limitations of the Study and Conclusion
The aim of this study was to gain profound insight into the com-
plex interactions of the Wnt and Hh signaling in healthy liver of
mice and humans and to elucidate of how these pathways jointly
regulate metabolic zonation of liver parenchyma. Collectively,
our results are based on a side-by-side investigation of two ma-
jor morphogen pathways together with the intensive use of tran-
scriptomics, proteomics, and metabolomics to provide insightinto structural features and regulation of metabolic zonation in
healthy adult mouse and human liver. The main findings were
(1) Wnt and Hh signaling dominate in distinct lobular regions
(pc and pp, respectively) and closely interact with each other
at various levels, mainly by mutual repression; (2) there is a
change in the paradigm that Hh signaling in the liver is controlled
by SHH rather than IHH, which might possibly act as an endo-
crine signal; (3) the Wnt/Hh module in the liver governs a huge
number of pp and pc metabolic functions where Hh inhibition
leads to a periportalization and Wnt activation results in strong
pericentralization, including striking extension of the pc zone;
and (4) bothmorphogen pathways seem to act similarly in human
liver. However, certain differences in the zonal distribution of
signaling components call for caution to simply transfer the find-
ings to the human situation. Nonetheless, it is obvious that any
modulation of the Wnt/Hh module may cause severe distur-
bance of liver metabolism in many of its facets.
The present study shows several limitations that should be
considered when drawing conclusions. These include the
following. (1) The non-inclusion of the non-parenchymal cell
(NPC) fraction in the analyses performed. We are well aware
that these cell populations significantly contribute to the com-
plex network in the liver because they express (and possibly
secrete) large amounts of both Wnt and Hh ligands (Machado
and Diehl, 2016). Intensive further analyses, however, are
needed before the NPC fraction can be integrated into our math-
ematical model. (II) Another limitation is the adequate interpreta-
tion of human data. Although we have used human liver samples
with an NAFLD (non-alcoholic-liver disease) activity score (NAS)
of 0–1, it is clear that they do not represent healthy individuals. It
is currently impossible to fully estimate the influence of the indi-
vidual lifestyle of patients and the medication they take on both
morphogen signaling and liver metabolism. Perhaps the devel-
opment and use of novel in vitro systems, such as in vitro orga-
noids, may improve this situation.STAR+METHODS
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Antibodies
Rabbit polyclonal anti-Axin2 (used for: IF) Abcam Cat # ab32197, RRID:AB_2290204
Mouse monoclonal anti-ACTB (used for: WB) Abcam Cat # ab8224, RRID:AB_449644
Mouse monoclonal anti-CTNNB1 (used for: IHC) BD Biosciences Cat # 610154, RRID:AB_397555
Rabbit polyclonal anti-FZD2 (used for: IHC) Alomone Cat # AFR-022, RRID:AB_2756591
Rabbit polyclonal anti FZD4 (used for: IHC) LSBio Cat # LS-B5723, RRID:AB_10912529
Rabbit polyclonal anti-GLI1 (used for: IHC) GeneTex Cat # GTX124274, RRID:AB_11174802
Rabbit polyclonal anti-GLI2 (used for: IHC) Biozol Cat # ORB378810
Rabbit polyclonal anti-GLI3 (used for: IHC) GeneTex Cat # GTX2605, RRID:AB_425213
Rabbit polyclonal anti-GLUL (used for: IF) Abcam Cat # ab49873, RRID:AB_880241
Rabbit polyclonal anti-IHH (used for: IF, IHC) Abcam Cat # ab39634, RRID:AB_881366
Rabbit polyclonal anti-PTCH1 (used for: IHC) LifeSpan Cat # LS-C122292, RRID:AB_10800195
Rabbit polyclonal anti-PTCH2 (used for: IHC, WB) LifeSpan Cat # LS-B301, RRID:AB_2269074
Rabbit polyclonal anti-WNT5a (used for: IHC) St. John’s Laboratory Cat # StJ26117
Goat biotinylated polyclonal anti-rabbit IgG (used for: IF) Millipore Cat # AP132B, RRID:AB_11212148
Extravidine-Cy3 (used for: IF) Sigma-Aldrich Cat # E4142
IRDye 800CW Goat anti-Rabbit (used for: WB) LI-COR Biosciences Cat # 926-32211, RRID:AB_621843
IRDye 680RD Goat anti-Mouse LI-COR Biosciences Cat # 926-68070, RRID:AB_10956588
Biological samples
human liver sections Christian-Albrechts University/
Leipzig University
N/A
murine liver sections Leipzig University N/A
murine hepatocytes Leipzig University N/A
Chemical, Peptides and Recombinant Proteins
Collagenase Type I, CLS I Biochrom Cat # C 1-22
Digitonin Sigma Cat # D141
INTERFERin VWR Cat # 409-50
rec. IHH R&D Cat # 1705-HH-025
rec. SHH R&D Cat # 464-SH-025
Critical Commercial Assays
EnVision+Dual Link System-HRP Agilent Cat # K406311-2
iST in-stage tip kit PreOmics Cat # P.O.00027
LightCycler FastStart DNA Master PLUS SYBR Green I Roche Cat # 03515869001
Maxima First Strand cDNA Synthesis Kit Thermo-Fisher Cat # K1671
peqGOLD RNAPure VWR Cat # 732-3312
Proto Script M-MuLV First Strand cDNA Synthesis Kit New England Biolabs Cat # E6300L
REVERT Total Protein Stain Kit LI-COR Biosciences Cat# P/N 926-11016
Rotor-Gene SYBR Green PCR Kit QIAGEN Cat # 204074
Tyramide SuperBoost Kit Thermo-Fisher, Cat # B40915
Tyramide SuperBoost Kit Thermo-Fisher Cat # B40922
Deposited Data
Metabolome analysis data of ApcWT versus Apchomo,
SAC-WT versus SAC-KO and pp versus pc C57Bl6N
hepatocyte supernatant
This Paper, LiSyM SEEK https://seek.lisym.org/data_files/439?
code=mpMmEN0lH10LB%2B%
2FMkYBAYDKtZKV9dJ%2Fu7wAQ7SIU
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Experimental Models: Organisms/ Strains
Mouse: Apchomo Shibata et al., 1997 N/A
Mouse: C57Bl6/N Medizinisches Experimentelles
Zentrum Leipzig
Internal breeding and hosting.
Mouse: SAC-KO Matz-Soja et al., 2014 N/A
Mouse: IHH-KO This Paper N/A




Actb Reverse Primer ATGGAGCCACCGATCCACA This Paper N/A
Apc Forward Primer CTCACTTACCGGAGCCAGAC This Paper N/A
Apc Reverse Primer GATTCCACAAAGTTCCACATGC This Paper N/A
Axin2 Forward Primer TGAAACTGGAGCTGGAAAGC This Paper N/A
Axin2 Reverse Primer AGAGGTGGTCGTCCAAAATG This Paper N/A
Ccnd1 Forward Primer GAGACCATTCCCTTGACTGC This Paper N/A
Ccnd1 Reverse Primer TGGTCTGCTTGTTCTCATCC This Paper N/A
Ctnnb1 Forward Primer GCAGCAGCAGTCTTACTTGG This Paper N/A
Ctnnb1 Reverse Primer CCCTCATCTAGCGTCTCAGG This Paper N/A
See table S5 for additional qPCR primer This Paper See Table S5
Apc siRNA GGACUGGUAUUAUGCUCAATT
UUGAGCAUAAUACCAGUCCTT
QIAGEN Cat # Mm_APC_1 (NM_007462)
Ctnnb1 siRNA GGGACGUUCACAACCGGAUUGUAAUA
UUACAAUCCGGUUGUGAACGUCCC
Invitrogen Cat # MSS202664
Gli1 siRNA CCCAACAUGGCAGUGGGUAACAUGAUCA
UGUUACCCACUGCCAUGUUGGG
Invitrogen Cat # MSS712 Gli1
Gli2 siRNA CCACAACCACAACGUUGCUCAGACA UGU
CUGAGCAAGCUUGUGGUUGUGG
Invitrogen Cat # MSS204726 Gli2
Gli3 siRNA UAGCAAGGCCAUCUUGGUCUUCAGG Invitrogen Cat # MSS204728 Gli3
See table S6 for additional siRNA sequences Invitrogen See Table S6
Recombinant DNA
GLI1 Promega/ KDRI FHC07737
GLI2 Promega/ KDRI FHC07749
GLI3 Promega/ KDRI FHC07751
Software and Algorithms
CorelDRAW Corel https://www.coreldraw.com/en/
Fiji (ImageJ) Schindelin et al., 2012 https://imagej.net/Fiji
R/iGraph https://igraph.org
Image Studio Light Li-Cor https://www.licor.com/bio/
image-studio-lite/
Ingenuity Pathway Analysis QIAGEN https://www.qiagenbioinformatics.
com/products/ingenuity-pathway-
analysis/
MaxQuant Cox and Mann, 2008 https://www.maxquant.org/
MetaboAnalyst Xia et al., 2015 https://www.metaboanalyst.ca/
PRISM7 GraphPad Software https://www.graphpad.com/




TiQuant Friebel et al., 2015 https://www.hoehme.com/software/
9-software/8-tiquant
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Madlen
Matz-Soja (madlen.matz@medizin.uni-leipzig.de). All mouse lines generated in this study are available from the Lead Contact with a
completed Materials Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human subjects
For human histology liver material from male and female patients with a NAFLD activity score (NAS) from 0-1 were included. Spec-
imen collection for all samples were approved by either Christian-Albrechts University (AZ: D 425/07; A 110/99) or Leipzig University
(AZ: 177/16-Ik) ethics committee. The informed consent was obtained from all subjects. The human liver material in this study was
obtained from male patients.
Murine subjects
For the study of Wnt/Hh signaling in the physiological state, 3 month old male C57BL6/N mice were used. For the investigation of the
inactivated Hh pathway and activated Wnt signaling in this study two transgenic mouse models were used. The SAC mice with a
hepatocyte-specific deletion of Smowith the expression of the Cre recombinase is under the control of the mouse albumin promoter
and the a-fetoprotein enhancer (Matz-Soja et al., 2014) and the Apchomomice bearing a homozygous floxed exon 14 in the Apc allele
(Shibata et al., 1997). SAC-WT, SAC-KO as well as APC-WT and APC-KO mice where sacrificed at the age of 12 weeks.
Triple transgenic mice allowing conditional hepatocyte-specific ablation of Ihh in response to exposure to doxycycline were gener-
ated by crossing the 129S4-Ihhtm1Blan/J mice (Jackson Laboratories) possess loxP sites flanking exon 1 of the targeted gene (Uh-
mann et al., 2007) with double transgenic LC-1/rTALAP1 mice (Scho¨nig et al., 2002). For inducing ablation of Ihh, mice were grown
up for 8 weeks under normal conditions. Then, expression of Cre recombinase was induced by adding doxycycline hydrochloride
(2 mg/ml) to the drinking water for a period of 10 days. Mice where sacrificed at the age of 12 weeks.
The mice were maintained in a pathogen-free facility on a 12:12 h light–dark cycle, according to the German guidelines and the
world medical association declaration of Helsinki for the care and safe use of experimental animals (permission numbers:
C57BL6/N mice: N03/14; SAC mice: T04/14, TVV 11; APC mice: T37/12 ; IHH mice: TVV44/16).
METHOD DETAILS
Maintenance of the mice and feeding
Themice weremaintained in a pathogen-free facility on a 12:12 h LD cycle. The animals had free access to regular chow (ssniffM-Z
V1124-0 composed of 22.0% protein, 50.1% carbohydrate, 4.5% fat; usable energy: 13.7 kJ/g; ssniff Spezialdia¨ten GmbH, Ger-
many) and tap water throughout life. The mice were studied at 3 months of age and sacrificed between 9 and 11 am after adminis-
tration of an anesthetic mixture of ketamine, xylazine and atropine.
Isolation and cultivation of primary mouse hepatocytes
The primary hepatocytes were isolated frommice by a collagenase perfusion technique as described before (Klingm€uller et al., 2006;
Gebhardt et al., 2010). By differential centrifugation the cell suspension was cleared of non-parenchymal cells (Matz-Soja et al.,
2014). Immediately after isolation the cells are incubated for 3-4 hours in Williams E medium (Millipore, F1115) for adherence with:
2 mM L-Glutamine, 42 mM Penicilin, 42 mM Streptomycin, 100 nM Dexamethasone as well as 10% (v/v) fetal calf serum. Afterward
there is a medium change with the sameWilliams Emedium without fetal calf serum. In this medium the cells are incubated. Medium
is changed every 24 hours. The serum-free medium was used for the analyses of the extracellular metabolites after the first 24 h of
incubation.
Isolation of primary periportal and pericentral mouse hepatocytes
Periportal and pc hepatocytes were isolated using digitonin-collagenase perfusion technique as described before (Burger et al.,
1989; Gebhardt 1998). In brief, for harvesting the respective cell fraction the liver was injected by digitonin for destruction of hepa-
tocytes from the opposite porto-central area. Digitonin injection was performed either retrograde (over vena cava inferior) for isolation
of pp hepatocytes or anterograde (over vena portae) for isolation of pc hepatocytes. Following the liver was perfused with collage-
nase. The cell suspension was cleared of non-parenchymal cells via differential centrifugation (Matz-Soja et al., 2014). Hepatocyte
culture conditions beyond seeding were performed analog to mixed cell population (see above).
RNA isolation and quantitative real-time PCR (qPCR)
Total RNA from hepatocytes and liver tissuewere extracted by peqGOLDRNAPure (VWR). The RNAwas reverse transcribedwith the
IM Prom II reverse transcriptase (Promega, Germany) and the Proto Script M-MuLV First Strand cDNA Synthesis Kit (New England
Biolabs) according to the manufacturer’s instructions. The resulting cDNA was quantified in duplicates by qPCR using the Rotor-e3 Cell Reports 29, 4553–4567.e1–e7, December 24, 2019
Gene SYBR Green PCR Kit and a Rotor-Gene Q (QIAGEN, Germany), as well as the LightCycler 2.0 Instrument and the
LightCycler FastStart DNA Master PLUS SYBR Green I (Roche, Germany) according to the manufacturer’s instructions. For
each target a gene-specific and intron-spanning primer was designed with Primer 3. For genes with no possibility for intron-spanning
primer Maxima First Strand cDNA Synthesis Kit (Thermo-Fisher, USA) was used. Using the standard curve method, the
absolute amount of the specific PCR products for each primer set was quantified. Actb (b-Actin) was amplified from each sample
for normalization as reference gene.
RNA interference
For all siRNA mediated knockdown experiments isolated hepatocytes from non-transgenic male C57BL/6N mice were used. The
specific siRNA and the respective nonsense oligo control siRNA were purchased from Invitrogen, Germany. The hepatocytes
were seeded at a density of 100,000 cells per well on 12-well plates. After 4 h, the cells were transfected with the respective siRNA
(10 nM) with INTERFERin (VWR, Germany) according to the manufacturer’s instructions. 24 h after transfection, the medium was
changed, and fresh medium without the siRNA was added. The changes in gene expression were analyzed by qPCR 48 h post
transfection.
GLI overexpression experiments
After isolation, hepatocytes from male C57BL/6N mice at the age of 12 weeks were cultivated at 0.25 Mio. cells per well in 6-well
plates in 1.5 ml medium (William’s Medium E enriched with 10% fetal calf serum, 2 mM L-glutamine, 100 nM dexamethasone and
Pen/Strep). After 3-4 h medium was changed and the transfection was performed analog (Matz-Soja et al., 2016).
In vitro IHH and SHH gain off function analysis
After isolation, hepatocytes from male C57BL/6N mice at the age of 12 weeks were seeded at a density of 100,000 cells per well on
12-well plates in 1.0 mlmedium (William’s Medium E enriched with 10% fetal calf serum, 2 mML-glutamine, 100 nM dexamethasone
and Pen/Strep). After 3-4 hmediumwas changed and freshmedia without fetal calf serum, but added recombinant protein for murine
IHH (rec. IHH, R&D, 1705-HH-025) and SHH (rec. SHH, R&D, 464-SH-025) and PBS as control was used. 24 h after treatment, the
medium was changed, and fresh medium with the recombinant proteins was added. The changes in gene expression were analyzed
by qPCR 48 h post treatment.
Immunohistochemistry
Immunohistochemistry on paraffin sections (3 mm) was performed as previously described (Zellmer et al., 2009). In brief, the sections
were deparaffinized, rehydrated and subsequently boiled in citric buffer (0.01 M sodium citrate, pH 6.0) or Tris/EDTA buffer (10 mM
Tris; 1 mM EDTA). Next the slides were incubated for 1 h min in 5% goat serum (Sigma-Aldrich, Germany) to block nonspecific bind-
ing. The following primary antibodies were used: anti AXIN2 (1:1000; Abcam, ab32197, UK), anti CTNNB1 (1:500; Transduction
Laboratories, 610054, USA), anti FZD2 (1:700; Alomone, AFR-022, Israel), anti FZD4 (1:500; LSBio, LS-B5723, USA) anti GLI1
(1:1500; GeneTex, GTX124274, USA), anti GLI2 (1:140; Biozol, ORB378810, Germany) anti GLI3 (1:1000; GeneTex, GTX26050,
USA), Sigma, Germany), anti GS (1:1000; Abcam, ab49873, UK), anti IHH (1:600; Abcam, ab39634, UK), anti PTCH1 (1:1000; LSBio,
LS-C122292, USA), anti PTCH2 (1:1000; LSBio, LS-B301, USA), anti WNT5a (1:500; St. John’s Laboratory, StJ26117, UK). Perox-
idase staining was performed using the EnVision+Dual Link System-HRP (Agilent, K406311-2, USA) according to manufacturer in-
structions. For immune fluorescence stainings Tyramide Super Boost Kits were used according to the manufacturer instructions
(Thermo-Fisher, B40922/ B40915, USA) and following antibodies were used: biotinylated goat anti-rabbit IgG (Millipore, AP132B,
Germany), Extravidine Cy3 (1:800; Sigma, E4142, Germany), goat anti mouse Cy3 (1:1000; Dianova, 115-167-003, Germany).
TiQuant - Protein quantification
Immunofluorescence double staining of AXIN2/GLUL on ApcWT versus Apchomo and on SAC-WT versus SAC-KOmice liver sections,
were analyzed by the modular image analysis software TiQuant (Friebel et al., 2015). TiQuant provides traditional pixel based image
processing pipelines suited for specific applications (Hammad et al., 2014) as well as a general supervoxel-based machine learning
approach to segment two- and three-dimensional images. The latter method was used for segmentation of the micrographs at hand.
First, an image is split into visually distinct, similarly sized regions, the so called supervoxels, using the SLIC0 algorithm (Achanta et
al., 2012). Each supervoxel is characterized by a set of features, comprising local, and neighborhood color histograms as well as
texture and gradient descriptors. An image is then annotated partially to provide training data in the form of labeled supervoxels.
A Random Forest classifier is fitted to the training data and subsequently used to predict class membership probabilities for each
supervoxel given their respective feature set. Segmentations are then inferred from these probabilities, and post-processed using
the watershed algorithm to separate clustered objects. Based on the obtained segmentations, the area of each staining in each in-
dividual micrograph was measured by pixel counting, and then statistically merged and analyzed.
Western Blot
The isolated hepatocytes were lysed in RIPA buffer using the Precellys 24 homogenizer. Equal quantities of protein lysate were sepa-
rated by an 8% SDS-PAGE followed by wet immunoblotting transfer on nitrocellulose membrane (Roth, Germany). The membraneCell Reports 29, 4553–4567.e1–e7, December 24, 2019 e4
was blocked in Odyssey Blocking Buffer (LI-COR Biosciences) and incubated with primary antibodies against PTCH2 (1:500;
LSBio, LS-B301, USA) and ACTB (1:1000; Abcam, ab8224, UK). Secondary antibodies IRDye 800CW Goat anti-Rabbit (LI-COR
Biosciences, 926-32211, USA) and IRDye 680RD Goat anti-Mouse (1:10000; LI-COR Biosciences, 926-68070, USA) were used
for visualization with the Odyssey Fc imager (LI-COR Biosciences). For normalization the amount of total protein was measured
via REVERT Total Protein Stain (LI-COR Biosciences) and analyzed by Image Studio 5.2 Software (LI-COR Biosciences).
Affymetrix chip array
Microarray analysis was conducted using liver material from IHH-WT and IHH-KO mice (n = 4 per genotype), at the microarray core
facility of the Interdisziplina¨res Zentrum f€ur klinische Forschung (IZKF) Leipzig (Faculty of Medicine, Leipzig University) described by
Zellmer et al. (2009). Briefly, GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix) were used for hybridization. The gene expression
data were pre-processed by Probe-level Linear Models using the ‘affyPLM’ packages of the Bioconductor Software.
Metabolome
Proteinogenic AA, ornithine, urea, pyruvate, acetoacetate, hydroxybutyrate, fumarate, a-ketoglutarate, malate, and citrate were
determined by GC–MS analysis as described (Hofmann et al., 2008; Maier et al., 2010). Lactate and bile acids were determined
by negative electrospray (ESI) LC–MS/MS in multiple-reaction-monitoring (MRM) mode on an Agilent 6460 triple quadrupole
mass spectrometer (Agilent, Waldbronn, Germany) coupled to an Agilent 1200 HPLC system. Ion pairing RP-HPLC separation of
lactate was performed similar to a describedmethod (Maier et al., 2010), andMRM transitions were 92/ 45 and 89/ 43 for lactate
and the internal standard [13C3]lactate, respectively. The bile acids b-muricholate, tauromuricholate, and taurocholate were sepa-
rated on a Poroshell 120 EC-C18 column (1003 2.1 mm, 2.7 mm particle size, Agilent) using a gradient of (A) 12 mm ammonium ac-
etate in water, and (B) acetonitrile as mobile phases at a flow rate of 0.5 ml/min. MRM transitions were 407.3/ 407.3 for b-muricho-
late, 514.3/ 80 for taurocholate and tauromuricholate, and 518.3/ 80 for the internal standards [2H4]tauromuricholate and [2H4]
taurocholate. The statistical and enrichment analysis of the obtained data was performed via the MetaboAnalystR software. In this
regards the samples were normalized by a pooled sample from the WT group in case of the transgenic animals and the pp group in
case of the hepatocytes from the pc and pp zone. After normalization the data were log transformed. For the quantitative enrichment
analysis the metabolic pathway associated metabolic library was chosen. The global test was used to analyze the Q-statistics for
each metabolite set.
Sample preparation for proteome profiling
The flow cytometry sorted cells were lysed at 95C for 10min in lysis buffer containing 1% sodium deoxycholate (SDC), 10mM tris(2-
carboxyethyl)phosphine (TCEP), 40 mM chloroacetamide (CAA), and 100 mM Tris pH 8.5. Incubation was followed by 5 min sonicat-
ion. The lysates were digested and purified using the preOmics in-stage tip kit (iST kit 96x, Martinsried, Germany). Samples were
eluted sequentially in three fractions using the SDB-RPS-1 and2 buffers (Kulak et al., 2014) and the elution buffer provided by preO-
mics for subsequent analysis on a nanoLC-MS.
LC-MS instrument settings for shotgun proteome profiling and data analysis
LCMS/MS was carried out by nanoflow reverse phase liquid chromatography (Dionex Ultimate 3000, Thermo Scientific, Waltham,
MA) coupled online to a Q-Exactive HF Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA). The LC separation was per-
formed using a PicoFrit analytical column (75 mm ID3 55 cm long, 15 mmTip ID (NewObjectives, Woburn, MA) in-house packed with
3-mm C18 resin (Reprosil-AQ Pur, Dr. Maisch, Ammerbuch-Entringen, Germany), as reported previously (Gielisch and Meierhofer,
2015). Briefly, peptides were eluted using a gradient from 3.8 to 50% solvent B in solvent A over 121 min at 266 nL per minute
flow rate. Solvent A was 0.1% formic acid and solvent B was 79.9% acetonitrile, 20% water, 0.1% formic acid. Nanoelectrospray
was generated by applying 3.5 kV. A cycle of one full Fourier transformation scan mass spectrum (3001750 m/z, resolution of
60,000 at m/z 200, AGC target 1e6) was followed by 12 data-dependent MS/MS scans (resolution of 30,000, AGC target 5e5)
with a normalized collision energy of 25 eV. In order to avoid repeated sequencing of the same peptides a dynamic exclusion window
of 30 s was used. In addition, only the peptide charge states between two to eight were sequenced.
Raw MS data were processed with MaxQuant software (1.5.7.4) (Cox and Mann, 2008) with the Andromeda search engine (Cox
and Mann, 2008) and the mouse UniProtKB with 51,416 entries released in 03/2016. A false discovery rate (FDR) of 0.01 for proteins
and peptides, a minimum peptide length of 7 AA, a mass tolerance of 4.5 ppm for precursor and 20 ppm for fragment ions were
required. A maximum of two missed cleavages was allowed for the tryptic digest. Cysteine carbamidomethylation was set as fixed
modification, while N-terminal acetylation and methionine oxidation were set as variable modifications. Determined up- or downre-
gulated proteins in the transgenic SAC-KO and Apchomo mice were overlaid onto a global molecular network developed from infor-
mation contained in the Ingenuity Pathways Knowledge Base. Networks of these focus genes were then algorithmically generated
based on their interrelationships.
In vitro knockdown experiments data analysis
Gene expression responses of ten Hh and 15 Wnt pathway genes were considered for selected siRNA knockdowns of 9 Hh (Ptch1,
Ptch2, Ptch1/2, Smo, Fused, Sufu, Gli1, Gli2, Gli3) and 2 Wnt pathway genes (Ctnnb1, Apc). A heatmap was created that provides ae5 Cell Reports 29, 4553–4567.e1–e7, December 24, 2019
global overview of expression responses associated with the specific knockdowns (Figure S3A). Columns represent responses of
individual genes to a specific knockdown. Rows represent the expression response of a specific gene across the different knock-
downs. Inhibition (blue), no change (gray) and activation (red) of a gene in response to a knockdown are highlighted and pathway
memberships of the individual genes are shown (green: Hedgehog, orange: Wnt).
Similarities between the different responses were analyzed by computing correlations between the response-specific gene
expression profiles (R function cor with option use = ‘‘pairwise.complete.obs’’ to account for missing values). This was done for
each pair of genes and the resulting correlation matrix was visualized as heatmap to identify subclusters.
The log2-fold expression changes enable to determine genes that tend to respond to knockdown of a specific gene. For each
knockdown, one can determine geneswhose absolute log2-fold expression change is greater than a fixed threshold.We used a strin-
gent log2-fold expression cutoff of 1 and a less stringent cutoff of 0.5 to determine which knocked down genes putatively influence
the expression of other genes (Figure S3B). Corresponding interaction networks were visualized using the R package igraph.
Details of the mathematical model
We use the following dependent variables in the model:
d a scalar field wð x!; tÞrepresenting Wnt ligand concentration
d a scalar field bð x!; tÞrepresenting intracellular Wnt pathway protein (AXIN) concentration
d a scalar field hð x!; tÞrepresenting sonic hedgehog ligand concentration
d a scalar field ið x!; tÞrepresenting indian hedgehog ligand concentration
d a scalar field gð x!; tÞ representing GLI3 protein concentration
We also use the quantities a for APC and c for SMO, but they are assumed to be spatially and temporally constant and only act as
adjustable parameters in the equations. As we do not attempt a quantitative analysis at this point, parameter values were chosen
manually to demonstrate sufficiency of the considered interactions for reproducing spatial staining patterns.
All variables are considered as dimensionless quantities, they are not scaled to any particular unit and their absolute magnitudes
need not be compared to each other.
A set of partial differential equations that is informed by measurements and qualitative observations is used for determining spatial
patterns of these quantities. The equations are then solved numerically for steady-state solutions using Morpheus (Starruß et al.,
2014).
For demonstration purposes we use a quadratic two-dimensional domain although for many conclusions a one-dimensional
domain is already sufficient. A grid size of 250x250 pixels is used (with one pixel representing 0.1 length units), a hexagonal central
vein pattern is superimposed on this grid. Each central vein has a radius of 5 pixels, the distance between two central veins is 100
pixels.






Here Ið x!Þ denotes the spatial-dependent production term of w. Ið x!Þ is set 1 at a central vein and 0.001 elsewhere. Hence, the equa-
tion assumes production of w predominantly at the central vein, diffusion and degradation.
The next equation for b reads as:








We assume activation of b by w, inactivation by a, expression limitation by h and degradation. The activation by w (Wnt) and inac-
tivation by a (APC) is very plausible as APC is known to block Wnt signaling in other systems (Gurley and Sa´nchez Alvarado, 2008).
The expression limitation by h is motivated by the SAC-KO experiments that resulted in an increase of manyWnt pathway genes (see
Figure 6A).
The next equation is for sonic hedgehog h:
ht = k3c k4wh+DhV2h
We assume SMO dependent expression (increasing SMO increases SHH), this is justified from the in-vitro data. Further we assume
Wnt dependent degradation (increasing WNT decreases SHH) and diffusion. The latter assumption is crucial for the increased
periportal h. Although it is not directly proven by an experiment it is indirectly supported by the negative correlation of WNT and
SHH (see Figure 7).
The equation for i reads as:
it = bc
2  k5i
This assumes production of i that depends on b and strongly on c (a linear term with respect to c does not work as well) and degra-
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And finally, the equation for g is:
gt = k6i + k7h k8g+DgV2g
Here we assume expression induced by i and h (the hedgehog ligands), degradation and diffusion. The assumption is supported by
the fact that GLI3 is logically downstream of the two hedgehog ligands. The assumption is also supported by similar behavior ofGli3,
Shh and Ihh in the in-vitro knockdown experiments.
The equations are integrated until a steady-state is achieved. The only spatial information that the model receives is the location of
the central veins via the function Ið x!Þ. This information produces a pericentral-periportal gradient inw and subsequently creates the
spatial patterns in all the other quantities.
For the control a= 0:2 and c= 1:0 are sedused. For Apchomo we use a= 0:1 and for SAC-KO we use c= 0:3.
In the simulations for the human samples we used the following settings: all equations are structurally the same but we use different
parameter values in the equation for w. I(x ) is defined to be 1.4 at the central vein and 0.4 elsewhere, k_1 = 1.0 and D_w = 0.2. The
parameters for the mathematical model were fitted manually (Table S7).
QUANTIFICATION AND STATISTICAL ANALYSIS
Most experiments were repeated 2-3 times with different quantities of biological replicates (n = 3 to 11) as indicated in each figure.
The number of technical replicates depended on the type of experiment and was mostly duplicates or triplicates. Outliers were iden-
tified with the ROUT test of GraphPad Prism 7 (aggressiveness 0.5%). Values are plotted as average of biological replicates ± stan-
dard error of the mean. The statistical evaluation was performed with the unpaired Student’s t test. The null hypothesis was rejected
at the p < 0.05 (*); p < 0.01 (**), p < 0.001 (***) and p < 0.0001 (****) levels.
DATA AND CODE AVAILABILITY
The proteome dataset supporting the current study have not been deposited in a public repository because the dataset is not public
because further publications based on this data are in progress, but are available from the corresponding author on request. In case
of the metabolom raw data please use the following link: https://seek.lisym.org/data_files/439?code=mpMmEN0lH10LB%2B%
2FMkYBAYDKtZKV9dJ%2Fu7wAQ7SIU. The published article includes all other datasets generated or analyzed during this study.e7 Cell Reports 29, 4553–4567.e1–e7, December 24, 2019
